16267322Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, van Deventer S, Goldblum R, Despain D, Hogge GS, Rutgeerts P, International Efficacy of Natalizumab as Active Crohn's Therapy (ENACT-1) Trial Group, Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial GroupThe New England journal of medicineAntibodies, Monoclonal; Cell Adhesion Molecules; Crohn Disease; Immunosuppressive Agents; Integrin alpha ChainsAdult; Antibodies, Monoclonal, Humanized; Double-Blind Method; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Natalizumab; Remission Induction; Treatment OutcomeNatalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med. 2005 Nov 03; 353(18):1912-25.N Engl J Med2005-11-03T00:00:002005Natalizumab induction and maintenance therapy for Crohn's disease.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000328Living Beings1578255770.254432AdultD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD007166Chemicals & Drugs2179770.66626Immunosuppressive AgentsD003424Disorders1197290.61584Crohn DiseaseD004311Procedures33818220.708936Double-Blind MethodD007577Living Beings550.997216JC VirusD007968Disorders10130.994514Leukoencephalopathy, Progressive MultifocalAuthorship 282914D005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617MaleD015815Chemicals & Drugs1031630.923431Cell Adhesion Molecules0.06983840.06983841authors10.2516has subject areaD016896Concepts & Ideas101179490.402389Treatment OutcomeD039001Chemicals & Drugs13140.989983Integrin alpha ChainsD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD0000694427210.990285NatalizumabD012074Procedures1657220.853019Remission InductionMedicineUniversity of ChicagoStephenHanauerStephen B. Hanauer41.78927490000000-87.60125000000000660Hanauer, StephenEmeritus/Emeritatrue1Emeritus/EmeritaEmeritus/Emerita